The Official Publication Of The Florida Pharmacy Association JAN. 2021
FACE MASKS & FACE SHIELDS
IMPROVE
YOUR PHARMACY OPERATIONS • Minimize dispensing errors • Increase revenue and profitability • Automate workflow management • Customize analytics and reports
Pharmacy Management System
Schedule a DEMO today!
(866) 495-3999
sales@micromerchantsystems.com
www.micromerchantsystems.com
Web portals and apps for patients, physicians and owners Turnkey refill management and automation RxSync – sync all refills to one date Two-way SMS/text message from the patient’s profile Route optimization through Google Maps Customizable workflow capabilities for Specialty, Mail Order and other pharmacy configurations Clinical assessment module
florida PHARMACY TODAY Departments 4 Calendar 4 Advertisers 5 Executive Insight 6 Call for Resolutions
VOL. 84 | NO. 1 JANUARY 2021 THE OFFICIAL PUBLICATION OF THE FLORIDA PHARMACY ASSOCIATION
Features
8 12 16
Masks and Face Shields
FDA Memorandum of Understanding with States on Compounded Human Drug Products Licensure Renewals Extended
A Message from the President My fellow Florida Pharmacy Association members I hope that everyone is doing well, and managing both family and career through these most challenging of times. I have some personal news to share with you as I embark on a new professional journey that has brought me to Washington, D.C., and the New York City area. As I will no longer be a resident of Florida, our governing documents do not allow for a non-resident member to serve as an FPA officer. So we have planned a smooth transition of my duties over to our current president-elect, Dr. Dan Buffington. I plan to remain available to leadership, but I assure you that FPA will be in good hands under Dan’s leadership. In closing let me thank the Florida Pharmacy Association members for giving me the great honor of allowing me to serve as your president. As I embark on my new professional journey, I will leave the Florida Pharmacy Association with eternal optimism for its future. Thank you, my friends. May God always bless you. Sincerely, Dr. Joseph Scuro
JANUARY 2021
|
3
Mission Statements:
FPA Calendar 2020
FEBRUARY 13
Building Your Profession Through Leadership Virtual Meeting
23
Student Advocacy Webinar
28
FPA awards nominations due MARCH
2
Legislative Session Begins
12-15 APhA Annual Meeting Virtual 20-21 FPA Council meetings TBD 23
Student Advocacy Webinar
APRIL 2
Good Friday, FPA office closed
17-18 FPA Regulatory and Law conference 30
Last day of the Legislative session MAY
9
Last day to submit resolutions to the House of Delegates
15-16 Clinical Conference 16-18 NASPA Leadership Retreat JUNE 8
Last day to submit items of new business to the House of Delegates
8
Last day to register for the House of Delegates summer session
FOR A COMPLETE CALENDAR OF EVENTS GO TO WWW.FLORIDAPHARMACY.ORG
Events calendar subject to change
CE CREDITS (CE cycle) The Florida Board of Pharmacy requires 10 hours’ LIVE continuing education as part of the required 30 hours’ general education needed every license renewal period. There is a two-hour CE requirement for pharmacists on the dispensing of controlled substances effective this biennial renewal period. Pharmacists and pharmacy technicians must also complete a one-hour Florida Board approved continuing education on human trafficking by Jan. 1, 2021. Pharmacists should have satisfied all continuing education requirements for this biennial period by Sept. 30, 2021, or prior to licensure renewal. Consultant pharmacists and technicians will need to renew their licenses and registrations by Dec. 31, 2020. For the Pharmacy Technician Certification Board application, exam information and study materials, please contact the FPA office. For more information on CE programs or events, please contact the Florida Pharmacy Association at (850) 222-2400 or visit our website at www.floridapharmacy.org CONTACTS FPA — Michael Jackson (850) 222-2400
FSHP — Tamekia Bennett (850) 906-9333 UF — Emely McKitrick (352) 273-5169
FAMU — Leola Cleveland (850) 599-3301 NSU — Carsten Evans (954) 262-1300
Florida Pharmacy Today Journal The Florida Pharmacy Today Journal is a peer-reviewed journal which serves as a medium through which the Florida Pharmacy Association can communicate with the profession on advances in the sciences of pharmacy, socio-economic issues bearing on pharmacy and newsworthy items of interest to the profession. As a self-supported journal, it solicits and accepts advertising congruent with its expressed mission.
Florida Pharmacy Today Board of Directors The mission of the Florida Pharmacy Today Board of Directors is to serve in an advisory capacity to the managing editor and executive editor of the Florida Pharmacy Today Journal in the establishment and interpretation of the Journal’s policies and the management of the Journal’s fiscal responsibilities. The Board of Directors also serves to motivate the Florida Pharmacy Association members to secure appropriate advertising to assist the Journal in its goal of self-support.
Advertisers APMS..................................................................... 8 MICRO MERCHANTS........................................ 2 PQC...................................................................... 20 PHARMACISTS MUTUAL.............................. 17 PSM..........................................................................
Note: The views of the authors do not necessarily represent the views or opinions of the Florida Pharmacy Association, Florida Pharmacy Today or any related entities.
DISCLAIMER Articles in this publication are designed to provide accurate and authoritative information with respect to the subject matter covered. This information is provided with the understanding that neither Florida Pharmacy Today nor the Florida Pharmacy Association is engaged in rendering legal or other professional services through this publication. If expert assistance or legal advice is required, the services of a competent professional should be sought. The use of all medications or other pharmaceutical products should be used according to the recommendations of the manufacturers. Information provided by the maker of the product should always be consulted before use.
4 |
FLORIDA PHARMACY TODAY
EMAIL YOUR SUGGESTIONS/IDEAS TO dave@fiorecommunications.com
Executive Insight BY MICHAEL JACKSON, RPH MICHAEL JACKSON, BPHARM, EVP & CEO, FLORIDA PHARMACY ASSOCIATION
P
The Winning Ticket is Membership
redicting the future could be good business for someone who knows how to do it and is accurate with their projections. As this article is being written, the Power Ball lottery is approaching the $1 billion threshold. Wouldn’t it be great if a quick pick dropped in your lap with all the winning numbers? If you won, what is first thing that you would do? The possibilities would be too much to imagine. I, for one, would finally have the resources to help make a difference in our profession. Yes, I am aware that sounds quite corny, but when you spend a sizable amount of time in professional advocacy, you become a part of its challenges and opportunities. We have been through some rough seas with pharmacy issues and the pandemic over the past year or so. We all agree it is about time that we find relief from the stormy weather, high winds and heavy rains of disruption. For too long the broken pharmacy payment model has tempered the desire for pharmacy entrepreneurship, and the compression of revenue has resulted in low profit margins for many businesses. This has even had a major impact on the growth of pharmacy jobs. Pharmacy work-life balance is not a forgotten issue, but is a major concern among our members. There is an answer out there but it takes more than a few volunteer leaders and supporters of our political committee to make a difference. For example, the seating capacity of the Dallas Cowboys football stadium is about 80,000. If you look at the number of Florida registered technicians and licensed pharmacists, we would fill that stadium and have another 7,000 to 8,000 standing outside waiting to get
in. Yet the membership of the Florida Pharmacy Association would fill only the number of seats available in a good sized high school gymnasium. In looking at the number of our members
For too long the broken pharmacy payment model has tempered the desire for pharmacy entrepreneurship, and the compression of revenue has resulted in low profit margins for many businesses. This has even had a major impact on the growth of pharmacy jobs. that regularly contribute to the Florida Pharmacist Political Committee, all you would need is a good sized classroom for a typical junior college biology class. I stand a better chance of being called up by the Tampa Bay Bucs to replace Tom Brady as quarterback than I would hitting the correct Power Ball numbers. Knowing that, we have to redirect our efforts to the vast number of member stakeholders who are not reading this article.
Michael Jackson, B.Pharm
Our association has done some amazing things over the years. We also have a lot of opportunities to address the things that need to be done. With your help, we can make that happen. Take a moment to add one more resolution to the things you want to cross through your list in 2021. If you are a member of our special #1 Club, recruit three new regular members. If you are not a member of the #1 Club, recruit 10 new regular members by convention and if you do, I’ll be happy to tell you what that effort will do for you. All it would take is a few phone calls and a simple ask. “Join the FPA and let’s make change happen.” So our choice is simple. Wait for the winning lottery numbers to come our way or connect with our nonparticipating stakeholders and invite them to join our advocacy campaign. The latter is much more likely to result in a favorable outcome. n
JANUARY 2021
|
5
FPA STAFF Executive Vice President/CEO Michael Jackson (850) 222-2400, ext. 200
Director of Continuing Education Tian Merren-Owens, ext. 120
Continuing Education Coordinator Stacey Brooks, ext. 210 Coordinator of Membership Christopher Heil, ext. 110
FLORIDA PHARMACY TODAY BOARD Chair............................... Carol Motycka, St. Augustine Vice Chair.........................Cristina Medina, Hollywood Treasurer.................................... Eric Jakab, Gainesville Secretary............................. Julie Burger, Pensacola Member.........................Michael Finnick, Jacksonville Member.............David Mackarey, Boynton Beach Member....................................... Matt Schneller, Tampa Member............................Teresa Tomerlin, Rockledge Member...................................... Greta Pelegrin, Hialeah Technician Member..........Julie Burger, Pensacola Executive Editor.......Michael Jackson, Tallahassee Managing Editor...................Dave Fiore, Tallahassee Journal Reviewer........................... Dr. Melissa Ruble Journal Reviewer....................................Dr. Angela Hill This is a peer-reviewed publication. . ©2021 FLORIDA PHARMACY JOURNAL, INC. ARTICLE ACCEPTANCE: The Florida Pharmacy Today is a publication that welcomes articles that have a direct pertinence to the current practice of pharmacy. All articles are subject to review by the Publication Review Committee, editors and other outside referees. Submitted articles are received with the understanding that they are not being considered by another publication. All articles become the property of the Florida Pharmacy Today and may not be published without written permission from both the author and the Florida Pharmacy Today. The Florida Pharmacy Association assumes no responsibility for the statements and opinions made by the authors to the Florida Pharmacy Today. The Journal of the Florida Pharmacy Association does not accept for publication articles or letters concerning religion, politics or any other subject the editors/publishers deem unsuitable for the readership of this journal. In addition, The Journal does not accept advertising material from persons who are running for office in the association. The editors reserve the right to edit all materials submitted for publication. Letters and materials submitted for consideration for publication may be subject to review by the Editorial Review Board.
FLORIDA PHARMACY ASSOCIATION
610 N. Adams St. • Tallahassee, FL 32301 850/222-2400 • FAX 850/561-6758 Web address: www.floridapharmacy.org.
CALL FOR RESOLUTIONS TO THE 2021 HOUSE OF DELEGATES The House of Delegates Board of Directors will meet in May 2021 to review and approve resolutions for the Annual Meeting. The deadline for submitting resolutions is May 9, 2021! PLEASE NOTE THIS DEADLINE. The last day to submit items of new business is June 8, 2021. The following information will be needed when submitting resolutions: 1. Name of organization: The name of the organization submitting the resolutions(s); 2. Name and telephone number of individuals: A contact in the event clarification or further information is needed; 3. Problem: A statement of the problem addressed by the resolution; 4. Intent: A statement of what passage of the resolution will accomplish; 5. Resolution Format: Please type and use double spacing. TITLE OF RESOLUTION NAME OF ORGANIZATION WHEREAS , AND
WHEREAS :
THEREFORE BE IT RESOLVED (THAT THE FPA OR SUBDIVISION OF FPA)
CONTACT NAME AND PHONE #: PROBLEM: INTENT:
Return this form to: Membership Coordinator, Florida Pharmacy Association, 610 North Adams Street, Tallahassee, Florida 32301 or fax (850) 561-6758
Protect your patients. Protect your pharmacy. ERR ORS C A N I NJ U R E PATIE NTS AND P U T YO UR PHAR M ACY I N F IN AN C IAL J EOPAR DY.
The PQC+ QA program can improve efficiency and increase patient safety as well as help you meet accreditation, credentialing, PBM and state Quality Assurance requirements. • Training, Quality Assurance CE, and resources • Patient Safety Organization protection for your QA work • Practical tools to collect and analyze patient safety data
Learn more at www.medicationsafety.org or call us at (866) 365-7472. The Alliance of Medication Safety (APMS) is a federally listed Patient Safety Organization (PSO).
Face Masks and Facial Shields By Thomas G. Baumgartner, Pharm.D., M.Ed., R.Ph., R.CPh.
The Centers for Disease Control and Prevention (CDC) and others (1) have now recommended that all United States citizens wear protective mask s to c urtail t he spread of COVID-19 contagion. Pharmacists, physicians, nurses and dietitians, not unlike other healthcare workers, must understand the importance of prevent ing microbial spread Thomas Baumgartner, Pharm.D., M.Ed., R.Ph., through the use of facial protection. R.CPh. Yet, unfortunately, mask-wearing to prevent the horrific onslaught of the (SARS-CoV-2) viral strain that causes Coronavirus Disease 2019 (COVID-19) has literally masked the identity of Americans, as well as, the global community. Further, the persistent threat of mask (surgical) and respirator (N95) shortages has caused a do-it-yourself approach for the development of homemade masks that may, indeed, be suboptimal. Although there are no convincing randomized, cross-over studies to show facial shield efficacy or safety and little time now to conduct them, one wonders why the use of standalone facial shields (or in combination with masks) shouldn’t be aggressively promoted today. There are many sensible reasons (Table 1) why shields (with or without mask use) may provide additional advantages. 1/6
Cursory study of facial shields has been shown to reduce immediate viral exposure (when worn by a simulated health care worker) by 96% within 18 inches of a cough and 92% at a distance of six feet. (2) However, the lack of a peripheral seal for facial shields has caused an element of hesitancy regarding its solitary use. As with a surgical mask, particularly if the sides are open or loose, the wearer is not completely protected from germ contact. There must also be a rigorous vigilance to avoid direct waves of air from ventilators, air conditioners or even page-turning breezes within six feet to avoid breaching of the shield or mask sides. Facial shields are typically made from a plastic material such as polycarbonate or polyethylene terephthalate glycol (PETG) found in water bottles that are, incidentally, recyclable. They provide an impenetrable barrier to both inhaled or exhaled microbials. A variety of shields are now available through pharmacies as well as the Internet and very reasonably priced. Optimally, proposed shields should encompass the entire head with an elastic-like material to comfortably fit all size heads (Fig 1), have good visibility (Fig 2), surround the head with air relief (Fig 3), fold up to eat (Fig 4), provide additonal eye protection (Fig 5), and rest on the shoulders when not in use (Fig 6). Surgical masks, or simply masks, reduce exhaled saliva and respiratory (cough, sneeze) secretions that can travel up to 27 feet. (3,4) The filtration capture of a particular 3/6type of mask will determine the relative efficacy of each type 2/6
FIG. 1 FIG. 3 8 |
FLORIDA PHARMACY TODAY
FIG. 2
of surgical mask. In the United States, these masks must conform to a bacterial filtration efficiency of more than 95% with entrapment of a 3 micron particle size. The SARS-CoV-2 virus particle size is 0.1-0.3 micron and, therefore, many times smaller than the surgical mask filtration capability. These surgical masks should not be confused with FFP3 respirators or N95 masks that are being reserved for healthcare workers since, although not completely optimal, they can trap the intake of 0.3 micron viral contaminants. Facial shields provide even more protection than face masks since they have the distinct advantage of preventing the direct inhalation of SARS- CoV-2 virus while providing similar mask exhalation protection using blockade. Again, although surgical masks will solely minimize/prevent exhalation transfer, they will not adequately prevent aerosolized viral inhalation. Shields, on the other hand, will provide an impenetrable barrier to any aerosolized intake and physically limit exhalation transmission. Facial shields will also provide a protective cover of choice if direct currents of air are unavoidable and social distancing cannot be respected. Keeping the hands away from the face (i.e., eyes, nose and mouth) may be, arguably, as important as hand washing or disinfection procedures. Likely, the most important reason to use a facial shield is to avoid hands-to-face transmission. Masks are usually uncomfortable and sometimes irritating, and this may cause repeated touching of face and contaminated frontal areas of masks. Keeping the hands away from the face (i.e., eyes, nose and mouth) may be, arguably, as important as hand washing or disinfection procedures. While all three of these protective elements (antisepsis, disinfection and no facial contact) are important, the costs of the personal protection equipment (PPE) are staggering compared to the conscious avoidance of facial touching. Therefore, simply minimizing facial touching with shield 4/6
5/6
FIG. 4
FIG. 5
blockade could significantly cost contain. The shield will also promote bonafide safety because the impenetrable barrier permits facial expression, as well as, visible communication thereby minimizing the muffled or no sound that can occur with masks. Emergent communication required during healthcare procedures or policing activity will foster expediency using shields. There is no question that shields will complement individual adherence through their comfortability. For example, shield use should promote dermal heat dissipation, less claustrophobia, less direct breathing resistance, easier fitting, irritation avoidance, less on/off touch contamination and easier oral (i.e., nutrients, medications) intake. The use of a plastic shield will provide eye protection by physically blocking the virus (or aerosolized particles containing the virus) from eye contact. Use of a shield also permits visibility without possible eyeglass fogging that can occur with masks, thereby fostering greater adherence. Further, since the nose frequently makes its way over a mask, a mask misuse or misfit may compromise the primary intention of blocking nasal exhalation. Removing masks for ingestion may cause multiple mask front/back touch contamination scenarios while shields allow easier oral intake. Shields will also, to some extent, address the problems of a tighter facial seal that almost never occurs as a consequence of facial hair layers and frequent mask positioning. The inexpensive shields require little expertise in design and fabrication. Production can be rapidly repurposed. Importantly, the face shield can be disinfected (using soap) and reused many more times (indefinitely) versus a maximum of three times (using UV or vaporized hydrogen peroxide) when using the n95 mask. Cloth masks should be washed with soap and water after each use and, of course, the front of the mask (and shield for that matter) should never be 6/6
FIG. 6 JANUARY 2021
|
9
Table 1. ADVANTAGES
SHIELDS
MASKS
Reduces Overall Facial Touching
YES
NO
Permits Facial Expression and Communication
YES
NO
Enhances Comfortability
YES
NO
Enables Eye Protection
YES
NO
Lessens nasal touch contamination risk
YES
YES
Lessens mouth touch contamination risk
YES
YES
Reduces Interference of Facial Hair
YES
NO
Promotes Easier Disinfection
YES
NO
Reduces Costs
YES
NO
Permits Easier Fabrication and Manufacture
YES
NO
Permits Easier Use in children, elderly, handicapped or diseased
YES
NO
touched to minimize the risk of transferring organisms. With the discovery of more children becoming inflamed/ infected with COVID-19 (currently greater than one million), the shield may offer safer protection (with or without masks) in children. This may also be true for the elderly, handicapped or diseased individuals when mask handling may be problematic. More in-depth predictive analyses of any and all signs and symptoms promises to give better direction relative to the kind of PPE that we should favor, as well as, their use at specific viral course intervals. Finally, if one is not yet convinced that shields offer additional protection (with or without masks) then at least consider the best materials for mask-making. A vacuum cleaner bag may be the material of choice since it may provide as much as 95% surgical mask effectiveness. High efficiency particulate air (HEPA) vacuum bags may filter up to 99.97% of 0.3 micron particles, thus trapping considerable concentrations of the SARS-CoV-2 virus. Dish towels may offer 69% protection while, in decreasing order, shirts, pillowcases or scarfs may not render nearly as much beneficial protection as a vacuum cleaner bag.(5) In sum, in-depth studies followed by intensive predictive analysis should be immediately completed to assess the true value of facial shields. Whereas, no clinical study has ever actually demonstrated efficacy with regard to viral testing and contact tracing, the same experiential measure might be presently implemented to support the aggressive use of facial shields (with or without masks) on a national and world stage. Respecting the criticality of these times, with the burden of more waves of viral morbidity and mortality, 10
|
FLORIDA PHARMACY TODAY
solitary (or complementary with masks) facial shields (with social distancing and wind current awareness) may, indeed, be a protective device of enhanced benefit. (6) Acknowledgement for stellar editing/reviewing to Susan L. Baumgartner, Pharm.D., MBA. References
1. Wang X, Ferro EG, Zhou G, Hashimoto D, Bhatt DL. Association between universal masking in a health care system and SARS-CoV-2 positivity among health care workers. JAMA. Published online July 14, 2020. doi:10.1001/jama.2020.12897 2. LindsleyWG,NotiJD,BlachereFM,SzalajdaJV, Beezhold DH. Efficacy of face shields against cough aerosol droplets from a cough simulator. J Occup Environ Hyg. 2014;11(8):509-518. 3. Bourouiba L, Dehandshoewoercker E?, Bush JWM. Violent respiratory events: on coughing and sneezing. ? J Fluid Mech. 2014;745:537-563. 4. Bourouiba L. Images in clinical medicine: a sneeze. N Engl J Med. 2016;375(8):e15. 5. van der Sande M, Teunis P, Sabel R (2008) Professional and Home-Made Face Masks Reduce Exposure to Respiratory Infections among the General Population. PLoS ONE 3(7): e2618. doi:10.1371/journal.pone.0002618. 6. Perencevich EN, Diekema DJ, Edmond MB.Moving Personal Protective Equipment Into the Community; Face Shields and Containment of COVID-19. April 29, 2020. doi:10.1001/ jama.2020.7477.
Dr. Baumgartner is President and Chief Executive Officer for Consultant Pharmacists of America, Inc., ConsultantPharmacistsofAmerica.com, consultantPharmacistsofAmerica@gmail.com, Gainesville, FL.
Vaccines are coming, but your patients still have questions. Help spread safety messaging by sharing these warnings about vaccine scams on social media. SAFEMEDICINES MEDICINES.orgÂŽ SAFE MEDICINES .orgÂŽ
PSM #covidscams
You can find these cards and more at http://safedr.ug/vaccine101
!
FAKE
Scammers sell fake vaccines, vaccines , but your pharmacist or doctor is a safe source.
SAFEMEDICINES SAFE MEDICINES.orgÂŽ MEDICINES .orgÂŽ
PSM
#covidscams
COVID vaccines won’t come from Amazon, AliBaba, or non-US pharmacies. Ask your doctor or pharmacist. SAFEMEDICINES SAFE MEDICINES.orgŽ MEDICINES .orgŽ
PSM #covidscams
Keep your patients safe while the vaccine rolls out nationwide.
SAFEMEDICINES.orgÂŽ
PSM #covidscams
JANUARY 2021 |
11
FDA Memorandum of Understanding with States on Compounded Human Drug Products By TJ Morton, FPA General Counsel
The compounding of prescription medications for patients has been a continuing service within the practice of pharmacy since the very beginning. There was a t i me when ma ny medications were not commercially available and had to be prepared by pharmacists. Some medications have to be customized to meet the unique needs of consumers who require specialized medication delivery TJ Morton systems. As we all are aware, the practice of pharmacy is regulated by state boards subject to the authority granted to them by the Legislature. The Food and Drug Administration (FDA) is that federal agency that regulates food, drugs, medical devices, cosmetics, vaccines and similar products. They generally do not regulate the practice of pharmacy. 12
|
FLORIDA PHARMACY TODAY
Pharmacy compounding has become a niche practice particularly with sterile compounding, which now has a rather comprehensive state regulatory framework. There are a number of FPA members who have a focused practice in this area and need to be aware of the Food and Drug Administration’s efforts to secure a signed memorandum of understanding with state pharmacy boards. If you are in this practice, this article should be important to you and your business, especially if you are shipping compounded medications outside of Florida. Below are key talking points on the issue. A comprehensive review of the FDA memorandum of understanding has been posted on the FPA web site. â–
In 1997, Congress created section 503a of the Federal Food, Drug, and Cosmetic Act (the FDCA). Section 503a regulates the compounding of human drug products by pharmacies.
AS WE ALL ARE AWARE, THE PRACTICE OF PHARMACY IS REGULATED BY STATE BOARDS SUBJECT TO THE AUTHORITY GRANTED TO THEM BY THE LEGISLATURE. THE FOOD AND DRUG ADMINISTRATION (FDA) IS THAT FEDERAL AGENCY THAT REGULATES FOOD, DRUGS, MEDICAL DEVICES, COSMETICS, VACCINES AND SIMILAR PRODUCTS. THEY GENERALLY DO NOT REGULATE THE PRACTICE OF PHARMACY. ■
■
■
■
■ ■
■
■
■
Section 503a exempts pharmacies that compound human drug products to fill patient-specific orders from the FDCA’s good manufacturing practice, labeling with adequate directions for use, and premarket approval requirements, provided that certain other requirements are met. One of these other requirements relates to whether the state in which the pharmacy is located has entered into a memorandum of understanding (MOU) with the FDA on compounded human drug products. If the state has entered into the MOU, there is no limit on the number of compounded human drug products that a pharmacy in such state may distribute out of state. (However, if the pharmacy distributes compounded human drug products out of state in quantities that exceed 50% of the total prescription orders dispensed or distributed by such pharmacy then the pharmacy will be reported to the FDA.) If the state has not entered into the MOU, no pharmacy located in such state may distribute compounded human drug products outside of the state in quantities that exceed 5% of the total prescription orders dispensed or distributed by such pharmacy. On October 26, 2020, the FDA announced that its MOU is available for signature by the states. The FDA’s announcement noted that states have until October 26, 2021, to sign the MOU. The FDA provided this time so that states have sufficient time to modify their laws or regulations, if necessary. The FDA’s announcement also stated that it will not begin enforcing the 5% limit on pharmacies in states that have not signed the MOU until October 26, 2021. The MOU requires any signatory state to investigate complaints relating to compounded human drug products shipped interstate and to report such complaints and investigations to the FDA. The MOU also requires any signatory state to identify on an annual basis any pharmacies that distribute inordinate
■
■
amounts of compounded human drug products interstate and notify the FDA of such pharmacies. In September 2019, the general counsel for the Florida Department of Health reviewed a 2018 draft of the MOU and opined that the Florida Board of Pharmacy could not enter into the MOU because it required the Board of Pharmacy to share information with the FDA that is deemed confidential under Florida law. The general counsel also determined that the MOU lacked certain provisions required by Florida law. Thus, unless the general counsel changes her opinion or Florida law is modified to allow for the state to sign the MOU, as of October 26, 2021, no Florida pharmacy may distribute compounded human drug products outside of the state in quantities that exceed 5% of the total prescription orders dispensed or distributed by such pharmacy.
T.J. Morton is a partner with the Lockwood Law Firm and serves and legal counsel for the Florida Pharmacy Association.
JANUARY 2021
|
13
SAVE THE DATE! 131st ANNUAL MEETING AND CONVENTION July 7 – 11, 2021
You don’t want to miss this event! General Education Track Consultant Education Track Student & Technician Track Social Distanced Special Events Exhibits • Receptions • Awards
Sawgrass Marriott Golf Resort & Spa Ponte Vedra Beach, FL
Room reservations can be made by calling (888) 821-1364. Room Rates: $179 plus tax based on single/double occupancy. The room reservation deadline is Friday, June 11, 2021 or when room block is full. Thereafter, reservations may be taken on a space available or rate available basis. There is an optional resort fee. Self-parking is discounted to $10 per day. Please be sure to ask for the Florida Pharmacy Association group rate. All reservations must be accompanied by a first night room deposit or guaranteed with a major credit card. The check-in time is 4:00pm and the checkout time is 11:00 am. 14
|
FLORIDA PHARMACY TODAY
1
FPA 131st Annual Meeting and Convention July 7-11, 2021 Ponte Vedra Beach, FL
,
55Daily Education Registration
Participant Information Participant Information
Daily registration does not include admittance to functions or handbooks. Handouts will be posted on our website July 6.
Name: _____________________________________________________ Name _______________________________________________ Address______________________________________________ Badge Name: _______________________________________________ City, State, Zip_________________________________________ Mailing Address: ____________________________________________ Phone___ ________________________ City, State, Zip: _____________________________________________ Email________________________________________________ Phone: (W) (H)_______________________ Practice Setting________________________________________ License: PS______________ PU _____________RPT_________ Fax: ______________________________________________________ NABP Date of Birth___________ License:e-profile#__________________ PS________________ PU_________ Other State________ Emergency Contact Name/Number_________________________
2
Before
June 18
Onsite
Amount
FPA Member
$165
$185
$_______
Non Member
$215
$235
$_______
Member Technician
$65
$85
$_______
Non Member Technician
$90
$110
$_______
Handbooks
$40
$40
$_______
Please select the day(s) you will attend: Thursday
Full Package Registration
Full package registration includes Educational Programs Thursday-Sunday, House of Delegates on Thursday, Exhibit Hall Friday and Saturday, Receptions, and Awards Event on Saturday. Handbooks are not included in full package registration. Handouts will be available the week of the convention on our website, www.floridapharmacy.org. Onsite
Amount_
6
Friday
Saturday
Sunday
Additional Tickets
The following events are included in the Full Registration Package, if requested. However, you must purchase additional tickets for guests who are NOT registered. Quantity
Price
Amount
Exhibit Hall
$30
$______
Awards Event
$80
$______
2FPA Member
Before June 18 $345
$430
$_______
Non Member
$525
$610
$_______
Pharmacist BEST Value
$540
$625
$_______
Member Technician
$155
$185
$_______
Non Member Technician
$175
$210
$_______
Technician BEST Value
$185
$220
$_______
$150
$170
$_______
Poster Presenter
$40
$40
$_______
(Registration fee is based upon membership and professional status for Non-convention registrants.)
3Student
Handbooks
(BEST Value includes Registration & Membership)
3
House of Delegates (Thursday)
FPPC Reception (Thursday)
Exhibit Hall (Friday and/or Saturday)
Awards Event (Saturday)
Christian Fellowship (Sunday)
I will not attend any of these functions.
4
House of Delegates
House of Delegates (Non-convention registrants)
Special Events Registration
The Poster Event is available to all pharmacy professionals and included in full and daily registrations. The Student Awards Event is not included in any registration packages. Quantity
8
_______
Amount $______
$50
$______
FPA Polo Shirt (Deadline is June 4) Quantity Price
9
Price
One Day Registration
Student Awards Event
Please indicate below which functions you will attend. If no boxes are selected, we will assume you will not attend any of the events listed below. Please see box 6 for additional tickets.
7
Yes
______
Payment
$35
M/F ______
Size ______
Amount $_______
Total Enclosed: $______
Check (To: FPA) AMEX Discover MasterCard Visa Account # ____________________________________________ Security Code _________________ Expiration Date __________
Before June 8 $165
Amount ______
Billing Address ________________________________________ Signature ____________________________________________
Four Ways to Register
Mail: FPA, 610 North Adams Street, Tallahassee, FL 32301 Phone: 850-222-2400 Fax: 850-561-6758 Web: www.floridapharmacy.org
Schedule and Fee Subject to Change
JANUARY 2021
|
15
LICENSURE RENEWALS EXTENDED Florida Surgeon General Scott Rivkees issued Emergency Order DOH No. 20-015 that extended licensure renewal deadlines to March 31, 2021. This primarily will affect pharmacy technicians and pharmacist consultants that are due to renew at the end of this month. This order, driven primarily by the ongoing public health emergency, will provide a three month grace period. Prescription department managers are encouraged to verify the registration status of pharmacy technicians. We learned a few weeks ago that there were a substantial number of technicians who have yet to renew their registrations. The emergency order also includes removes the option for the parent or guardian of a child to refuse to have the child immunization records included in the state’s immunization registry (See F.S. 381.003 (1) (e) 2 and 3). That action also suspends a law that would allow a college or university student health center or clinic in Florida to refuse to be included in the immunization registry. Pharmacy providers should make sure that immunizations provided to children and adults have been recorded in Florida Shots.
JOIN TODAY!
16
|
FLORIDA PHARMACY TODAY
Protect your Tomorrow with VISTA
Our VISTA business package policy protects your tomorrow with: • Commercial Liability • Cyber Liability • Sexual Misconduct and Physical Abuse • Employment Practices Liability • Pharmacy Professional Liability • Commercial Property • Coverage Enhancements
Additional Coverage Options
• Pharmacist Professional Liability • Pharmacy Technician Professional Liability • Workers’ Compensation • Commercial Auto • Commercial Umbrella • Executive Liability including: • Directory and Officers Liability • Employment Practices Liability • Fiduciary Liability • Surety and Fidelity Bonds • Life - Business and Personal Coverage • Group Disability
LEARN MORE AT: phmic.com/vista-pharmacy Professional | Commercial | Personal | Life & Disability
phmic.com
Executive Liability, Surety and Fidelity Bonds, Life, and Disability insurance are written through PMC Advantage Insurance Services, Inc., a wholly-owned subsidiary of Pharmacists Mutual Insurance Company.
JANUARY 2021
|
17
C A L L
F O R
APhA Foundation and NASPA Bowl of Hygeia Awarded to a pharmacist for outstanding community service above and beyond professional duties. The use of the following selection criteria is required: ■ The recipient must be a Florida licensed pharmacist and a member of FPA. ■ ■ T recipient has not previously received the award. ■ two on its award committee or an officer of the association other than in an ex officio capacity. ■ has compiled an outstanding record of community service, which, apart from his/her specific identification as a pharmacist, reflects well on the profession. Beal and Powers Pharmacist of the Year Award Awarded to the “Pharmacist of the Year.” Criteria: ■ must be a Florida registered pharmacist and a member of the FPA. ■ has rendered outstanding service to pharmacy within the past five years. Technician of the Year Award Awarded annually to a Florida pharmacy technician who is recognized for his/her outstanding performance and achievement during his/her career. Criteria: ■ Candidate must be a member of the Florida Pharmacy Association for at least two years. ■ Candidate must have demonstrated contributions and dedication to the advancement of pharmacy technician practice.
18
|
FLORIDA PHARMACY TODAY
N O M I N A T I O N S ■ Candidate must have demonstrated
contributions to the Florida Pharmacy Association and/or other pharmacy organizations. ■ Candidate must have demonstrated commitment to community service. ■ Candidate is not a past recipient of this award. R.Q. Richards Award This award is based on outstanding achievement in the field of pharmaceutical public relations in Florida. Criteria: ■ recipient must be a Florida registered pharmacist and a member of the FPA. ■ has displayed outstanding achievement in the field of pharmaceutical public relations in Florida. Frank Toback/AZO Consultant Pharmacist Award Criteria: ■ Candidate must be an FPA member, registered with the Florida Board of Pharmacy as a consultant pharmacist in good standing. ■ Candidate should be selected based on their outstanding achievements in the field of consultant pharmacy. DCPA Sidney Simkowitz Pharmacy Involvement Award Presented annually to a Florida pharmacist who has been active at the local and state pharmacy association level in advancement of the profession of pharmacy in Florida. Criteria: ■ A minimum of five years of active involvement in and contributions to the local association and FPA. ■ Candidate must have held office at local level pharmacy association. ■ Member in good standing for a period of at least five years in the FPA and must have served as a member or chairman of a committee of the association.
F P A
■ Candidate must have been active-
ly involved in a project that has or could potentially be of benefit to members of the profession.
Pharmacists Mutual Companies Distinguished Young Pharmacist Award Awarded to a young pharmacist for their involvement and dedication to the practice of pharmacy. Criteria: ■ Licensed to practice for nine years or fewer. ■ Licensed to practice in the state in which selected. ■ Participation in national pharmacy association, professional programs, and/or community service. IPA Roman Maximo Corrons Inspiration & Motivation Award Interamerican Pharmacists Association created this award to honor the memory of Roman M. Corrons who inspired and motivated countless pharmacists to participate actively and aspire to take on leadership roles in their profession. Roman was always there with guidance and support that motivated pharmacists and encouraged visionary leadership, approachable active membership and succession planning. This award recognizes the motivators among us who inspire others to continue to advance the profession. Criteria: ■ The recipient must be a Florida Licensed Pharmacist and a member of the FPA. ■ Candidate should motivate others to excel within the profession by encouraging them to be leaders. ■ Candidate is not necessarily an association officer, but guides, supports and/or inspires others. A brief description on the candidate’s motivational/inspirational skills must accompany the nomination.
A W A R D S
2 0 2 0 - 2 0 2 1
The Jean Lamberti Mentorship Award The Jean Lamberti Mentorship Award was established in 1998 to honor those pharmacists who have taken time to share their knowledge and experience with pharmacist candidates. The award is named in honor of long time FPA member Jean Lamberti for her effort in working with pharmacy students. Criteria: ■ The recipient must be an FPA member. ■ The recipient must serve as a role model for the profession of pharmacy.
Upsher Smith Excellence in Innovation Award Awarded to honor practicing pharmacists who have demonstrated innovation in pharmacy practice that has resulted in improved patient care. Criteria: ■ The recipient has demonstrated innovative pharmacy practice resulting in improved patient care. ■ The recipient should be a practicing pharmacist within the geographic area represented by the presenting Association. Qualified Nominee: A pharmacist practicing within the geographic area represented by the presenting Association.
DEADLINE FOR NOMINATIONS: FEBRUARY 28, 2021 FPA AWARDS NOMINATION FORM I AM PLEASED TO SUBMIT THE FOLLOWING NOMINATION:
NOMINATED BY:
Name:
Name:
Address:
Date Submitted: Signature:
FOR THE FOLLOWING AWARD: APhA Foundation and NASPA Bowl of Hygeia Beal and Powers Pharmacist of the Year Award R.Q. Richards Award
Please describe briefly below the nominee's accomplishments, indicating why you feel he or she should receive this award. (Attach additional sheets if necessary.)
Frank Toback/AZO Consultant Pharmacist Award DCPA Sydney Simkowitz Award Pharmacists Mutual Co. Distinguished Young Pharmacist Award IPA Roman Maximo Corrons Inspiration & Motivation Award The Jean Lamberti Mentorship Award Upsher Smith Excellence in Innovation Award
MAIL NOMINATONS TO: Annual Awards, Florida Pharmacy Association, 610 N. Adams St., Tallahassee, FL 32301 (850) 222-2400 FAX (850) 561-6758 DEADLINE FOR NOMINATIONS IS FEBRUARY 28, 2021
JANUARY 2021
|
19
“I’M ALWAYS WATCHING OUT FOR MY PATIENTS, BUT WHO’S WATCHING OUT FOR ME?”
WE ARE. We are the Alliance for Patient Medication Safety (APMS), a federally listed Patient Safety Organization. Our Pharmacy Quality Commitment (PQC) program: • • • •
Helps you implement and maintain a continuous quality improvement program Offers federal protection for your patient safety data and your quality improvement work Assists with quality assurance requirements found in network contracts, Medicare Part D, and state regulations Provides tools, training and support to keep your pharmacy running efficiently and your patients safe
Call toll free (866) 365-7472 or visit www.pqc.net PQC IS BROUGHT TO YOU BY YOUR STATE PHARMACY ASSOCIATION
